Surface modified protein microparticles

Details Surface modified protein microparticles Surface modified protein microparticles

2007-05-15

2007-05-15

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Coated, impregnated, or colloidal particulate

C424S001110, C424S001370, C424S001650

Reexamination Certificate

active

10463833

ABSTRACT:
A microparticle contains a cross-linked protein shell, and a surface coating.

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 5294369 (1994-03-01), Shigekawa et al.
patent: 5362478 (1994-11-01), Desai et al.
patent: 5439686 (1995-08-01), Desai et al.
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5505932 (1996-04-01), Grinstaff et al.
patent: 5508021 (1996-04-01), Grinstaff et al.
patent: 5512268 (1996-04-01), Grinstaff et al.
patent: 5560933 (1996-10-01), Soon-Shiong et al.
patent: 5635207 (1997-06-01), Grinstaff et al.
patent: 5639473 (1997-06-01), Grinstaff et al.
patent: 5648506 (1997-07-01), Desai et al.
patent: 5650156 (1997-07-01), Grinstaff et al.
patent: 5665382 (1997-09-01), Grinstaff et al.
patent: 5665383 (1997-09-01), Grinstaff et al.
patent: 5914806 (1999-06-01), Gordon II et al.
patent: 5930026 (1999-07-01), Jacobson et al.
patent: 5972493 (1999-10-01), Iwasaki et al.
patent: 6068600 (2000-05-01), Johnson et al.
patent: 6156292 (2000-12-01), Quay
patent: 6231834 (2001-05-01), Unger et al.
patent: 6246892 (2001-06-01), Chance
patent: 6246901 (2001-06-01), Benaron
patent: 6249271 (2001-06-01), Albert et al.
patent: 6262706 (2001-07-01), Albert et al.
patent: 6262833 (2001-07-01), Loxley et al.
patent: 6264917 (2001-07-01), Klaveness et al.
patent: 6264918 (2001-07-01), Johnson et al.
patent: 6280704 (2001-08-01), Schutt et al.
patent: 6300932 (2001-10-01), Albert
patent: 6312304 (2001-11-01), Duthaler et al.
patent: 6315981 (2001-11-01), Unger
patent: 2002/0054912 (2002-05-01), Kim et al.
patent: 2004/0058458 (2004-03-01), Anker et al.
Ai, H., M. Fang, S. Jones &Y. Lvov, “Electrostatic layer-by-layer nanoassembly on biological microtemplates: platelets,”Biomacromolecules,3:560-564, 2002.
Amsden, B., “The production of uniformly sized polymer microspheres,”Pharm. Res.,16:1140-1143, 1999.
Amsden, B. & M. Gossen, “An examination of factors affecting the size, distribution, and release characteristics of polymer microbeads made using electrostatics,”J. Control. Release,43:183-196, 1997.
Barton, J., J. Hoying, & C. Sullivan, “Use of microbubbles as an optical coherence tomography contrast agent,” Contrast Material Research Conference, Sep. 12-17, 1999, Woodstock, VT,inAcademic Radiology 9 (Supp. 1):S52-S55, 2002.
Boppart, S., B. Bouma, C. Pitris, J. Southern, M. Brezinski & J. Fujimoto, “In vivo cellular optical coherence tomography imaging,”Nature Med.,4:861-865, 1998.
Boppart, S., B. Bouma, C. Pitris, G. Tearney, J. Southern, M. Brezinski & J. Fujimoto, “Intraoperative assessment of microsurgery with three-dimensional optical coherence tomography,”Radiology,208:81-86, 1998.
Boppart, S., B. Bouma, C. Pitris, G. Tearney J. Fujimoto & M. Brezinski, “Forward-imaging instruments for optical coherence tomography,”Optics Letters,22:1618-1620, 1997.
Boppart, S., M. Brezinski, B. Bouma, G. Tearney & J. Fujimoto, “Investigation of developing embryonic morphology using optical coherence tomography,”Devel. Biol.,177:54-63, 1996.
Boppart, S., M. Brezinski, C. Pitris, & J. Fujimoto, “Optical coherence tomography for neurosurgical imaging of human intracortical melanoma,Neurosurgery,”43:834-841, 1998.
Boppart, S., B. Bouma, M. Brezinski, G. Tearney & J. Fujimoto, “Imaging developing neural morphology using optical coherence tomography,”J. Neurosci. Meth.,70:65-72, 1996.
Boppart, S., G. Tearney, B. Bouma, J. Southern, M. Brezinski & J. Fujimoto, Noninvasive assessment of the developingXenopuscardiovascular system using optical coherence tomography,Proc. Natl. Acad. Sci. USA,94:4256-4261, 1997.
Bouma, B., G. Tearney, S. Boppart, M. Hee, M. Brezinski & J. Fujimoto, “High-resolution optical coherence tomographic imaging using a mode-locked Ti:AI2O3laser source,”Optics Letters,20:1486-1488, 1995.
Bouma, B., G. Tearney, C. Compton & N. Nishioka, “High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography,”Gastrointest. Endosc.,51:467-474, 2000.
Brezinski, M., G. Tearney, B. Bouma, J. Izatt, M. Hee, E. Swanson, J. Southern & J. Fujimoto “Optical coherence tomography for optical biopsy: properties and demonstration of vascular pathology,”Circulation,93:1206-1213, 1996.
Bugaj, J., S. Achilefu, R. Dorshow & R. Rajagopalan, “Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform,”J. Biomed. Opt.,6:122-133, 2001.
Burns, R., J. Klaunig, J. Shulok, W. Davis & P. Goldblatt, “Tumor-localizing and photosensitizing properties of hematoporphyrin derivative in hamster buccal pouch carcinoma,”Oral Surg. Oral Med. Oral Pathol.,61:368-372, 1986.
Caruso, F., R. Caruso, & H. Möhwald, “Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating,”Science,282:1111-1114, 1998.
Chen, Z., T. Milner, S. Srinivas, X. Wang, A. Malekafzali, M. van Gemert & J. Nelson “Noninvasive imaging of in vivo blood flow velocity using optical doppler tomography,”Optics Letters,22:1119-1121, 1997.
Christiansen, C., H. Kryvi, P. Sontum & T. Skotland, “Physical and biochemical characterization of Albunex™, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin,”Biotechnol. Appl. Biochem.,19:307-320, 1994.
de Boer, J., T. Milner, M. van Germert, & S. Nelson, “Two-dimensional birefringence imaging in biological tissue by polarization-sensitive optical coherence tomography,”Optics Letters,22:934-936, 1997.
Decher, G., “Fuzzy Nanoassemblies: Toward layered polymeric multicomposites,”Science,277:1232-1237, 1997.
Desai, N., P. Soon-Shiong, M. Grinstaff, Z. Yao, P. Sandford, K. Suslick & P. Soon-Shiong, “Controlled and targeted drug delivery with biocompatible protein shell microspheres,” Abstract from 20thAnnual Meeting of Society of Biomolecules, Apr. 4-9, 1994, Boston, MA,Proc. Soc. Biomaterial,20:112, 1994.
Dick, A., G. Adam, J. Tacke, A. Prescher, T. Southon & R. Günther, “Computed tomography of experimental liver abscesses using a new liposomal contrast agent,”Invest. Radiology,31:194-203, 1996.
Drexler, W., U. Morgner, F. Käftner, C. Pitris, S. Boppart, X. Li, E. Ippen & J. Fujimoto, “In vivo ultrahigh-resolution optical coherence tomography,”Optics Letters,24:1221-1223, 1999.
Freeman, R., K. Grabar, K. Allison, R. Bright, J. Davis, A. Guthrie, M. Hommer, M. Jackson, P. Smith, D. Walter & M. Natan, “Self-assembled metal colloid monolayers: an approach to SERS substrates,”Science,267:1629-1632, 1995.
Fu, K., D. Pack, A. Klibanov, & R. Langer, “Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres,”Pharmac. Res.,17:100-106, 2000.
Fujimoto, J., M. Brezinski, G. Tearney, S. Boppart, B. Bouma, M. Hee, J. Southern & E. Swanson, “Optical biopsy and imaging using optical coherence tomography,”Nature Medicine,1:970-972, 1995.
Gazelle, G., G. Wolf, G. McIntire, E. Bacon, E. Halpern, E. Cooper & J. Toner, “Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging,”Acad. Radiol.,1:373-376, 1994.
Geny, B, P. Bischoff, B. Muan, F. Piquard, J. Thiranos, E. Epailly, M. Lambrechs, A. Juelsrud-Vebner, B. Eisenmann & P. Haberey, “Safety of a new transpulmonary echocontrast agent (Albunex®) in repeated echocardiographic studies in patients,”Clin. Cardiol.,20:111-115, 1997.
Gram, T., “Drug absorption and distribution,”in Modern Pharmacology with Clinical Applications.(Craig, CR, R. Stitzel, eds. Little, Brown, & Co., Inc., Boston, MA), pp. 13-24, 1997.
Grinstaff, M. & K. Susl

Affiliated with

Also associated with

Rating

Surface modified protein microparticles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Surface modified protein microparticles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surface modified protein microparticles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3805922